Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients-Reference-Cited by-同舟云学术

Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients

Published:2016-04 Issue:4 Volume:64 Page:807-812
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hullegie Sebastiaan J.,Claassen Mark A.A.,van den Berk Guido E.L.,van der Meer Jan T.M.,Posthouwer Dirk,Lauw Fanny N.,Leyten Eliane M.S.,Koopmans Peter P.,Richter Clemens,van Eeden Arne,Bierman Wouter F.W.,Newsum Astrid M.,Arends Joop E.,Rijnders Bart J.A.

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam;Vanhommerig;J Acquir Immune Defic Syndr,2014

2. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies;Micallef;J Viral Hepat,2006

3. Current knowledge and future perspectives on acute hepatitis C infection;Hullegie;Clin Microbiol Infect,2015

4. Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin;Santantonio;Hepatology,2014

5. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort;Vogel;Antivir Ther,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals;Viruses;2022-09-02

2. Molecules Containing Cyclobutyl Fragments as Therapeutic Tools: A Review on Cyclobutyl Drugs;Current Medicinal Chemistry;2022-06-10

3. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression;The Lancet HIV;2022-06

4. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study;The Lancet HIV;2021-02

5. Management of Patients with Acute Hepatitis C;Hepatitis C: Care and Treatment;2021